首页|食欲素受体拮抗剂类抗失眠药物的研究进展

食欲素受体拮抗剂类抗失眠药物的研究进展

扫码查看
随着现代社会生活节奏的加快,失眠的患病率逐渐增加,长期失眠会严重影响个人的工作和生活.目前临床常用的改善失眠症状的药物主要为镇静催眠药.作为新一代抗失眠药物,食欲素受体拮抗剂可以增加睡眠各阶段的持续时间、减弱觉醒信号从而抑制清醒状态而非诱导镇静,从而可以有效避免传统镇静催眠药物的一些缺点.本研究对食欲素受体拮抗剂中3个明星药物suvorexant、lemborexant、daridorexant的有效性和安全性进展进行综述,以期为治疗失眠提供参考.
Research Progress of Anti-Insomnia Drugs of Orexin Receptor Antagonist
With the acceleration of modern life,the prevalence of insomnia is gradually increasing,which can significantly impact individuals'work and life.Currently,the primary medications used to alleviate insomnia symptoms in clinical practice are sedative-hypnotic drugs.As a new generation of anti-insomnia drugs,orexin receptor antagonists can increase the duration of each stage of sleep,weaken the arousal signal,thus inhibiting wakefulness rather than inducing sedation,and effectively avoiding some disadvantages of traditional sedative-hypnotic drugs.This article provides a review of the research progress of the efficacy and safety of three prominent drugs,suvorexant,lemborexant,and daridorexant,as orexin receptor antagonists,aiming to provide reference for the treatment of insomnia.

orexin receptor antagonistshypnotic drugsefficacysafetyreview

于景娴、池里群

展开 >

北京市海淀区妇幼保健院药剂科,北京 100080

食欲素受体拮抗剂 抗失眠药物 有效性 安全性 综述

2024

中国合理用药探索
中国执业药师协会

中国合理用药探索

影响因子:0.62
ISSN:2096-3327
年,卷(期):2024.21(2)
  • 38